|
000
| 01541cam 2200265za 4500 |
|---|
| 001 | 9.696685 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107134519 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407s2012||||onca||||o f00| 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-4/2012E-PDF|zH82-4/2009E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 10|aPMPRB Compendium of policies, guidelines and procedures |h[electronic resource]. |
|---|
| 250 | |aUpdated |
|---|
| 260 | |aOttawa : |bPatented Medicine Prices Review Board |cJune 2012. |
|---|
| 300 | |a49p. : |bfigs., tables. |
|---|
| 500 | |a"Implementation: January 1, 2010"--Cover. Incorrect ISBN (978-1-100-12984-6) printed in this publication. |
|---|
| 500 | |aThis publication is also available at : http://www.publications.gc.ca/site/eng/9.696685/publication.html. |
|---|
| 500 | |aIssued also in French under title: CEPMB Compendium des politiques, des lignes directrices et des procédures. |
|---|
| 520 | 3 |aEnsures that patentees are aware of the policies, guidelines and procedures under which Board Staff reviews the prices of patented drug products sold in Canada, and the procedures normally undertaken in the scientific and price review processes and when a price appears to be excessive. |
|---|
| 590 | |a12-39|b2012-09-28 |
|---|
| 775 | 08|tCEPMB Compendium des politiques, des lignes directrices et des procédures |w(CaOODSP)9.640792 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s372 KB|uhttps://publications.gc.ca/collections/collection_2012/cepmb-pmprb/H82-4-2012-eng.pdf |
|---|